1970
DOI: 10.1021/bi00805a018
|View full text |Cite
|
Sign up to set email alerts
|

Calf intestine adenosine deaminase. Substrate specificity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
26
0

Year Published

1973
1973
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(29 citation statements)
references
References 10 publications
3
26
0
Order By: Relevance
“…While we have previously demonstrated (Marquez and colleagues) that this enzyme efficiently deaminates nucleoside analogs in the north conformation (43)(44)(45)(46), the kinetic analysis of ADA that we report here shows that the presence of a substituent at the 2 position of the adenine base makes these derivatives poor substrates for ADA. These results agree with previous studies reporting that 2-halo-substituted compounds are not efficiently deaminated by ADA (29,(31)(32)(33). The mechanism by which 2-halo substitutions affect ADA activity does not appear to involve steric interactions in the ADA binding pocket (Fig.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…While we have previously demonstrated (Marquez and colleagues) that this enzyme efficiently deaminates nucleoside analogs in the north conformation (43)(44)(45)(46), the kinetic analysis of ADA that we report here shows that the presence of a substituent at the 2 position of the adenine base makes these derivatives poor substrates for ADA. These results agree with previous studies reporting that 2-halo-substituted compounds are not efficiently deaminated by ADA (29,(31)(32)(33). The mechanism by which 2-halo substitutions affect ADA activity does not appear to involve steric interactions in the ADA binding pocket (Fig.…”
Section: Discussionsupporting
confidence: 92%
“…The enzyme adenosine deaminase (ADA), which is present at high concentrations in human serum, is involved in the catabolism of dA and its analogs (27,28). ADA is responsible for the deamination of adenosine or deoxyadenosine analogs to inosine-or deoxyinosine-based products (27,(29)(30)(31)(32)(33) and can therefore affect the activation pathway and intracellular concentration of dA-based compounds. For example, ADA converts dideoxyadenosine (ddA) to ddI, leading to a different and indirect activation pathway for ddA (28,34,35).…”
mentioning
confidence: 99%
“…Furthermore, 2ClAdo is a low potency inhibitor of adenosine deaminase (19), an enzyme that regulates intracellular nucleotide concentrations. However, the effects of 2ClAdo could not be mimicked by N-ethylcarboxamidoadenosine, a purinergic P 1 agonist with similar receptor potencies to 2ClAdo, nor by reversible (erythro-9-(2-hydroxy-3-nonyl)adenine) or irreversible (deoxycoformycin) adenosine deaminase inhibitors ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…However, it is known that 3-deazaadenosine is neither a substrate nor an inhibitor of adenosine deaminase (10), that 3-deazaadenosine nucleotideis a poorer substrate for polymerase than is the parent compound (11), and that 3-deaza-6-methylthiopurine ribonucleotide is 1/1000 as inhibitory as its parent compound (2). These properties of the 3-deaza analogs parallel somewhat those of the 8-substituted nucleoside and it is natural to consider the same explanations for the inactivity of the 3-deaza analogs already given for the 8-substituted derivatives (15)(16)(17)(18)(19), i.e., that substrates for certain enzymes must be present in the anti conformation. In this regard the 3-deaza analogs may prove to be useful models for assessing the hypothesis of an optimized rotamer for enzymic recognition once there is assurance that N3, per se, is not used to bind the nucleoside to the enzyme.…”
mentioning
confidence: 84%